-
Trump’s Inflation Fix Centers on Energy Emergency That Doesn’t Exist
Economists and analysts aren’t convinced that an expansion of oil and gas production will lower consumer prices.
-
Bank of Japan Raises Interest Rates to Highest Level Since 2008
The return of inflation and wage growth is giving the Bank of Japan room to raise interest rates and declare the end of a long period of stagnation.
-
For Investors, the Business of America Is Still Business
Our columnist suggests how to think about stocks and bonds during a presidency that is signaling a deep devotion to profits.
-
Chevron to Increase Output at Huge Oil Field in Kazakhstan
The energy giant is spending nearly $50 billion to expand the Tengiz oil field, allowing it to pump one million barrels a day.
-
Many Jan. 6 Rioters Pardoned by Trump Attacked Police, Videos Show
President Trump pardoned men who violently attacked police officers on Jan. 6 along with nearly 1,600 other people who had been charged in connection with the riot. But his grant of clemency did not erase the video evidence of their crimes.
-
Trump Pulls the Military Back Into the Political and Culture Wars
The removal of a portrait of Gen. Mark A. Milley, the former chairman of the Joint Chiefs of Staff, from a Pentagon hallway was among the president’s early actions.
-
Trump Officials Move to Quickly Expel Migrants Biden Allowed In Temporarily
A memo appears to allow Immigration and Customs Enforcement officials to target programs that let in more than a million people.
-
From Fires to Mudslides, Catastrophe Has Defined Newsom’s Tenure
Gov. Gavin Newsom faces what may be his greatest political test and leadership challenge. He planned to greet President Trump upon his arrival in Southern California on Friday.
-
Trump to Visit North Carolina and California, With Disaster Aid an Open Question
While he has expressed support for North Carolina residents, the president has criticized California’s Democratic leaders and threatened to withhold federal aid from the state.
-
FDA Finalizes Guidance on Communications Regarding Unapproved Uses of Medical Products
On January 7, the U.S. Food and Drug Administration (FDA) finalized its October 2023 guidance document titled “Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products” (the final guidance). This guidance finalizes the draft issued in October 2023, and while most of the concepts from the initial…
